StreetAlpha.app
Home › Stocks › ENOV

Enovis CORP (ENOV)

Industrials
$25.47
▼ −2.90%
LAST CLOSE · NOV 20

Enovis makes medical devices for injury prevention, rehabilitation and joint reconstruction, sold to surgeons, clinicians and consumers. It last closed at $25.47 on Nov 20, down 2.90% on the day. The next earnings report for ENOV is expected around Thu, Feb 25, 2027. For the quarter ended Oct 2026, ENOV reported EPS of $0.06 on revenue of $558.7M, with revenue up 1.8% from a year ago. Over its last 8 reports the stock moved an average of 10.3% the session after earnings. Over the last 12 months ENOV insiders bought $962K of stock on the open market and sold $45K, according to SEC Form 4 filings.

AI Auto Pilots
Is ENOV in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ENOV.

Key Stats

Last 12 months
Results
Revenue
$2.3B
+3.3% vs a year ago
Net income
−$527.4M
−22.9% margin
EPS (diluted)
−$9.23
Free cash flow
$69.6M
3.0% margin
Valuation
Market cap
$1.5B
57.7M shares
P/E
–
No P/E while losing money
Price to sales
0.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$13.0M
At Oct 2
Debt
$1.3B
At Oct 2
Shareholder equity
$1.5B
Shares outstanding
57.7M
At Oct 30
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $1.4B$1.4BFY2021FY2022: $1.6B$1.6BFY2022FY2023: $1.7B$1.7BFY2023FY2024: $2.1B$2.1BFY2024FY2025: $2.2B$2.2BFY2025

From ENOV's SEC filings, latest 10-Q for the period ending Oct 2, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 25
Estimated date · Time not announced
Reported EPS
$0.06
Quarter ended Oct 2026
Year ago EPS
-$9.99
Same quarter last year
Revenue
$558.7M
+1.8% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$12.70Dec '24Apr 2025: -$0.98Apr '25Jul 2025: -$0.64Jul '25Oct 2025: -$9.99Oct '25Dec 2025: -$9.11Dec '25Apr 2026: -$0.15Apr '26Jul 2026: -$0.02Jul '26Oct 2026: $0.06Oct '26Latest $0.06
Revenue by quarter
Dec 2024: $561.0MDec '24Apr 2025: $558.8MApr '25Jul 2025: $564.5MJul '25Oct 2025: $548.9MOct '25Dec 2025: $575.8MDec '25Apr 2026: $589.2MApr '26Jul 2026: $582.8MJul '26Oct 2026: $558.7MOct '26Latest $558.7M
How ENOV moved after its last 8 reports
Average move the session after a report ±10.3%
Nov 5, 2026Time not announced+17.2%
Aug 6, 2026Time not announced−12.8%
May 7, 2026Time not announced+9.7%
Feb 26, 2026Time not announced+13.9%
Nov 6, 2025Time not announced−9.8%
Aug 7, 2025Time not announced+10.7%
May 8, 2025Time not announced−3.4%
Feb 26, 2025Time not announced−5.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ENOVStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ENOV
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ENOV

Technical Analysis

ENOV · as of the Nov 20 close · updated each morning
Turning up

The stock is 1% above its 20 day and 16% above its 50 day average. It is 8% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 54). The nearest support is the swing low (Jul 23) at $25.40, and the nearest resistance the Pivot at $25.82.

Short trendBullish
Long trendNeutral
MomentumNeutral
StretchNormal
VolatilityHigh, 5.7%/day
Key levels
$31.6652 week high+24.3%
$26.50Swing high (Jul 7)+4.0%
$26.27Pivot R1+3.1%
$25.82Pivot+1.4%
$25.47Last close
$25.40Swing low (Jul 23)−0.3%
$25.1820 day average−1.1%
$25.03Pivot S1−1.7%
$23.35200 day average−8.3%
$23.30100 day average−8.5%
$21.3050 day average−16.4%
$16.7052 week low−34.4%
Indicators
RSI (14)54.26Middle of its rangeNeutral
MACD1.65Below its signal lineBearish
Stochastic62.5Middle of its rangeNeutral
ADX (14)40.7Strong uptrend
Williams %R-46.3Oversold below −80, overbought above −20Neutral
CCI (20)14.7Oversold below −100, overbought above 100Neutral
Rate of change−6.2%Change over 10 sessionsBearish
ATR (14)$1.44Typical daily range, 5.7% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ENOV

What happened before

See how ENOV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ENOV usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ENOV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2008.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ENOVHow many large options trades hit ENOV, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

ENOV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼106 buying vs 152 selling
  • ▲Held by funds +24.1 pts
  • ▼Funds holding -8
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding249257−3.1%
In funds' top 1031+200.0%
Held by funds146.4%122.3%+24.1 pts
New / increased41 / 6541 / 87−17.2%
Reduced / sold out104 / 4890 / 46+11.8%
Put/call ratio0.000.04−100.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ENOV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ENOV Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$962K17 buys · 5 insiders
Sold$45K1 sale · 1 insider
Cluster buy: 2 insiders bought $199K between Nov 6 and Nov 13.
2025-12 sold $45K2026-02 bought $26K2026-03 bought $120K2026-06 bought $92K2026-09 bought $450K2026-11 bought $199KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 13Angela S LalorDirectorBuy1,754$28.16$49K
Nov 11Angela S LalorDirectorBuy1,757$28.57$50K
Nov 11Sharon L WienbarDirectorBuy1,774$28.09$50K
Nov 9Sharon L WienbarDirectorBuy1,831$27.26$50K
Sep 4Oliver EngertChief Administrative OfficerBuy2,660$18.80$50K
Sep 4Damien McDonaldCEOBuy13,035$19.15$250K
Every insider buy and sale for ENOV over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See ENOV insider trades →

From SEC Form 4 filings by ENOV's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ENOV is in one of them and how their past ENOV trades turned out.

ENOV in the AI portfolios
Loading…

ENOV News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ENOV in an article yet. Here's the latest on the wider market.

ENOV in the news

About Enovis

Enovis is a medical technology company based in Lewisville, Texas. It makes medical devices in two main areas. One covers braces, compression garments, bone growth stimulators and therapy products used for injury prevention and rehabilitation. The other covers implants and surgical instruments for joint replacement, limb reconstruction and foot and ankle procedures. Its customers include orthopedic surgeons, physical therapists, other healthcare professionals, healthcare systems, athletes and retail consumers.

Headquarters
Lewisville, TX